Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MAGEA9B///MAGEA9 |
| Upstream (Parents) |
|---|
| (<<) RNF144A → MAGEA9B///MAGEA9 |
| (<<) BCL6 → MAGEA9B///MAGEA9 |
| (<<) AANAT → MAGEA9B///MAGEA9 |
| (<<) DUX1///DUX3///DUX5 → MAGEA9B///MAGEA9 |
| (<<) C2orf67 → MAGEA9B///MAGEA9 |
| (<<) KCTD7 → MAGEA9B///MAGEA9 |
| (<<) DDX60 → MAGEA9B///MAGEA9 |
| Downstream (Children) |
|---|
| MAGEA9B///MAGEA9 → GAGE8///GAGE12F///GAGE2A///GAGE2D///GAGE12J///GAGE12G///GAGE2B///GAGE2E///GAGE12I///GAGE7///GAGE6///GAGE5///GAGE4///GAGE3///GAGE2C///GAGE1 (>>) |
| MAGEA9B///MAGEA9 → LOC727842 (>>) |
| MAGEA9B///MAGEA9 → MAST4 (>>) |
| MAGEA9B///MAGEA9 → GAGE12D///GAGE12F///GAGE2A///GAGE12H///GAGE12E///GAGE12B///GAGE12C///GAGE12G///GAGE2B///GAGE2E///GAGE12I///GAGE7///GAGE6///GAGE5///GAGE4///GAGE2C (>>) |
| MAGEA9B///MAGEA9 → CDH4 (>>) |
| MAGEA9B///MAGEA9 → KIAA0913///SAT1 (>>) |
| MAGEA9B///MAGEA9 → SHC1 (>>) |
| MAGEA9B///MAGEA9 → AANAT (>>) |
| MAGEA9B///MAGEA9 → DUX1///DUX3///DUX5 (>>) |
| MAGEA9B///MAGEA9 → LOC729915///LOC728093///POM121L3P///POM121L10P///LOC440821///POM121L4P///POM121L8P///POM121L9P///POM121L1P (>>) |
| MAGEA9B///MAGEA9 → ELL2 (>>) |
| MAGEA9B///MAGEA9 → TBL1X (>>) |
| MAGEA9B///MAGEA9 → PSD (>>) |
| MAGEA9B///MAGEA9 → CDC5L (>>) |
